Hormone-Refractory Prostate Cancer Terminated Phase 1 / 2 Trials for Bicalutamide (DB01128)

Also known as: Hormone Refractory Prostate Cancer Disease / Hormone Refractory Prostate Cancer / Castration-resistant prostate cancer / Hormone refractory prostate cancer (disorder)

IndicationStatusPhase
DBCOND0030169 (Hormone-Refractory Prostate Cancer)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01020305Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate CancerTreatment